Karyopharm Therapeutics (KPTI) Fails to deliver data

Key failure to deliver metrics for Karyopharm Therapeutics :

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: NZ$0.04 M
• Last 3 months FTD volume: NZ$0.1 M
• Last year FTD volume: NZ$0.1 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Karyopharm Therapeutics (KPTI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Karyopharm Therapeutics (KPTI) - since 2013

Karyopharm Therapeutics (KPTI) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Merck MRK	NZ$14.45 M	NZ$88.44 M	🇺🇸 USA
Bristol-Myers Squibb BMY	NZ$29.95 M	NZ$0.31 B	🇺🇸 USA
Abbott Laboratories ABT	NZ$24.54 M	NZ$0.13 B	🇺🇸 USA
Exelixis EXEL	NZ$5.76 M	NZ$11.62 M	🇺🇸 USA